What does AmCad BioMed Corporation do?

AmCad BioMed Corporation (4188.TWO) operates in the Software - Application industry within the Technology sector. Full company description, peers, and segment breakdown are on the page above.

What is 4188.TWO's market cap?

AmCad BioMed Corporation (4188.TWO) has a market capitalization of approximately $924.7 million, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 4188.TWO pay a dividend?

No — AmCad BioMed Corporation (4188.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is 4188.TWO profitable?

AmCad BioMed Corporation (4188.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

4188.TWO

AmCad BioMed Corporation

TWO·Software, Application · Technology

NT$14.60NT$1.30+9.77%

Market capNT$924.66M·Aug 26 5:20 AM UTC

Price Chart

NT$14.60+NT$1.30 (+9.77%)today

−13.10%CAGR −2.77%

Select date range

FromTo

Dec 26, 2013Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

4188.TWO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMay 14

Last Report DateJun 30

Reported vs Estimate−NT$0.25

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$28.60M

Net Income−NT$56.98M

Net Margin−199.2%

Operating Cash Flow−NT$47.31M

Capital ExpendituresNT$120.00K

Free Cash Flow−NT$47.43M

Return on Equity−11.1%

Return on Invested Capital−3.7%

Net CashNT$328.54M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 4188.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 4188.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 4188.TWO and 80,000+ other tickers.

About AmCad BioMed Corporation

AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems; and AmCAD-UB, an AI…

CEO: Yi Li Lee
Sector: Technology
Industry: Software - Application
Exchange: TWO
Employees: 69,576
Website: www.amcadbiomed.com

Peers

Puriblood Medical Co., Ltd.

Cap

NT$1.1B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 4188.TWO

What does AmCad BioMed Corporation do?: AmCad BioMed Corporation (4188.TWO) operates in the Software - Application industry within the Technology sector. Full company description, peers, and segment breakdown are on the page above.
What is 4188.TWO's market cap?: AmCad BioMed Corporation (4188.TWO) has a market capitalization of approximately $924.7 million, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 4188.TWO pay a dividend?: No — AmCad BioMed Corporation (4188.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is 4188.TWO profitable?: AmCad BioMed Corporation (4188.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.